Why repair is preferred over replacement in primary MR
When a durable mitral valve repair is feasible, it is strongly preferred over replacement. The survival advantage, preservation of LV function, and lower reoperation risk make repair the standard of care at experienced centers — when the anatomy allows it.
The recommendation is not that repair is always better. It is that when repair is durable, it is almost always better. That distinction — when feasible, when durable — is where clinical judgment enters.
Key takeaway
Durable mitral valve repair in experienced hands is associated with better survival, better LV function preservation, and lower long-term risk than replacement. Repairability — not just severity — determines the approach, and repairability requires experienced assessment.
Key points
- Surgical repair preserves the native valve and subvalvular apparatus, maintaining LV geometry and function post-operatively.
- Long-term survival after repair is superior to replacement in matched populations — the benefit is most pronounced in patients undergoing repair before LV dysfunction develops.
- Freedom from reoperation is high (>85% at 10–15 years) for experienced repair centers performing posterior leaflet repair.
- Anterior leaflet and bileaflet prolapse carry lower repair durability rates — appropriate patient selection and center expertise matter.
- Repair likelihood should be assessed at a valve center before concluding that replacement is necessary.
When to read this
You are discussing intervention options for a patient with severe primary MR. You want to understand why repair is the preferred approach and what makes it feasible.
What repair preserves
Mitral valve replacement — whether mechanical or bioprosthetic — severs the connections between the leaflets, chordae, and papillary muscles. That subvalvular apparatus is not merely a structural tether: it transmits forces from the ventricular wall through the chordae to the leaflets, and those forces contribute to LV shape and contractile mechanics. Removing the native apparatus results in a measurable, often permanent reduction in LV ejection fraction of 5–10 percentage points, particularly in patients with borderline LV function preoperatively. Repair preserves the entire apparatus and avoids this penalty.
The survival data
Multiple observational and quasi-experimental studies have compared repair and replacement in severe primary MR. The consistent finding is a survival advantage for repair that emerges over 5–10 years and persists through follow-up. The advantage is largest in younger patients, in patients with preserved LV function, and in high-volume repair centers. At specialized centers, repair rates for degenerative MR exceed 90%, and 15-year freedom from reoperation for posterior leaflet prolapse is above 85%.
When repair is less durable
Not all primary MR is equally repairable. Posterior leaflet prolapse — the most common etiology — is highly amenable to resection or neochordal repair. Anterior leaflet prolapse is more technically demanding and repair durability is lower at centers with lower volume. Bileaflet prolapse, Barlow disease with extensive myxomatous change, and heavy calcification of the annulus reduce repair success rates. Endocarditis with leaflet destruction, rheumatic disease with leaflet fibrosis, and congenital cleft mitral valve each require individualized assessment.
Repairability requires experienced assessment
The ACC/AHA VHD 2020 guideline links the repair-preferred recommendation explicitly to experienced centers and likely durable repair. When repair durability is uncertain, the benefit over replacement narrows and the calculus shifts. This is why referral to a valve center — rather than a decision based on echo findings alone — is the recommended pathway for all patients in whom intervention is being considered. The repairability assessment requires direct intraoperative visualization, not just preoperative echo.
TEER is not a substitute for repair in primary MR
Transcatheter edge-to-edge repair (TEER, e.g., MitraClip) reduces regurgitation without open surgery by clipping the leaflets together. In secondary MR, TEER has a stronger evidence base. In primary MR, TEER is considered when surgical risk is high or prohibitive — not as a first-line alternative to open repair in operable patients. The EVEREST II trial comparing TEER to surgery in primary MR showed inferior reduction of MR and higher rates of reoperation with TEER, despite lower procedural risk. Anatomy also limits TEER applicability in primary MR — flail leaflet height and orifice size must be within specific parameters for the device to clip effectively.
Repair likelihood is not a bedside call
Telling a patient that repair is preferred does not mean you can confirm repair is feasible from a TTE or even a TEE alone. A valve center evaluation — with surgical assessment — is required to confirm that a durable repair is achievable before framing the intervention decision around that premise.
See also
Related valve learning
Apply this in practice
Use the Primary MR Intervention Navigator to evaluate when and how to proceed.
Primary MR Intervention Navigator